🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

SILO SILO

Company Profile ↓
$4.61
-57.67% 1Y
Mkt Cap$4.09M
P/E-0.61
P/B0.65
52W High$12.22
52W Low$4.19
Book Value$7.10
EPS (TTM)$-7.50

Company Overview

SILO (SILO) is a publicly traded company listed on with a market capitalization of $4.09M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 12.2% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $72.10K (+0.0% YoY); net profit $-4.23M.
  • Trailing 12 Months Year-on-year growth — revenue +0.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 12.2%.

Growth & Price Performance

Compounded Sales Growth

5 Years:12.19%
1 Year:0.00%

Stock Price Performance

1 Year:-57.67%
6 Months:-3.66%
3 Months:-31.86%
1 Month:-18.55%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 5% of range
$4.19 $12.22
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)42.96 · Neutral
Price Performance
1M-18.55%
3M-31.86%
6M-3.66%
1Y-57.67%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 12.2% over 5 years.

CONS

  • Trading 62.3% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.61
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$7.10
Price to Book
0.65
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
12.19%
Profit 5Y
-
Revenue (YoY)
0.00%
Earnings (YoY)
-

Profitability & Returns

ROCE
-61.55%
ROE
-67.05%
ROA
-55.59%
Profit Margin
-
Op Margin
-
Gross Margin
38.57%
EPS (Latest Qtr)
$-1.80
EPS (TTM)
$-7.50

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
11.36
Debt
-
Total Assets
$7.02M
Current Assets
$6.80M
Working Capital
$6.74M

Ownership

Promoter Holding
16.41%
Chg in Prom Hold
-
FII / Inst Holding
11.13%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$72.10K
EBITDA
$-4.18M
Free Cash Flow
$-5.24M
Operating Cash Flow
$-4.66M
Shares Outstanding
887.88K
Gross Margin
38.57%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2012Jun 2012Sep 2012Mar 2013Jun 2013Sep 2013Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -----------2682942.22K16.29K47.43K68.08K--18.02K18.02K18.03K18.02K18.02K18.03K18.02K18.02K-18.03K18.02K18.02K18.03K18.03K
Cost of Revenue ----------------------------1.46K1.46K20.69K20.69K20.69K
Gross Profit -----------186210883-13.16K16.56K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K-16.57K16.57K-2.66K-2.66K-2.66K
Operating Expenses ----------------------------1.11M1.27M1.15M783.86K1.59M
Operating Income -------134.85K-76.11K-81.18K-174.56K-189.87K-242.51K-159.36K-996.69K-558.89K-901.14K-436.85K-463.94K-527.26K-494.29K-949.15K-803.49K-1.11M-773.40K-879.51K-1.00M-1.01M--1.09M-1.25M-1.15M-786.52K-1.59M
EBITDA -----------------------------1.03M-1.20M-1.11M-845.89K-1.64M
Interest Expense ----------------------------2.07K1.65K88632.70K3.37K
Pretax Income -----------------------------1.03M-1.20M-1.11M-881.53K-1.65M
Tax Provision ----------------------------00000
Net Income -13.04K-5.67K-8.55K-22.88K-22.48K-5.74K17.55K-315.91K-198.16K-123.52K-242.21K-265.48K-238.88K-1.38M-633.79K-930.70K-461.99K6.39M-604.07K-658.40K-983.25K-906.40K-1.01M-660.16K-801.67K-931.78K-928.81K--1.03M-1.20M-1.11M-881.53K-1.65M
Diluted EPS ------0.00-0.010.00-0.01-0.01-0.01---0.010.000.003.160.00--0.49-0.29-0.32-0.21-0.28-0.31-0.22--3.45-2.85-1.80--1.80
R&D Expense ---------------48.60K98.85K70.51K170.28K105.68K375.80K202.91K130.72K174.50K318.24K392.82K517.55K-593.96K717.25K543.62K-1.01M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ----40.57K40.92K-72.10K72.10K72.10K72.10K
Cost of Revenue -------5.84K5.84K5.84K44.30K
Gross Profit ----13.18K-135.20K-66.26K66.26K66.26K27.81K
Operating Expenses -------3.71M3.92M4.77M4.31M
Operating Income ---490.87K-594.24K-930.40K-2.20M--3.65M-3.86M-4.71M-4.28M
EBITDA --------3.91M-3.63M-4.38M-4.18M
Interest Expense -------2.20K4.87K5.08K37.30K
Pretax Income --------3.91M-3.63M-4.39M-4.23M
Tax Provision -------0000
Net Income -49.80K-39.45K356.54K-969.46K-1.01M-3.04M--3.91M-3.70M-4.39M-4.23M
Diluted EPS --0.01-0.02--0.05--25.65-18.00-17.85-7.50
R&D Expense -----26.25K693.91K1.29M845.09K2.37M2.16M

Balance Sheet (Annual)

Figures in USD.

Metric Jul 2010Dec 2010Dec 2011Dec 2012Dec 2013Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -47.48K1.75K2792.21M-1.64M855.42K493.85K1.43M-11.64M7.75M7.41M7.61M
Current Assets -----------11.57M7.68M7.11M7.39M
Cash & Equivalents 047.48K1.75K2792.01M579.21K294.59K336.68K111.75K1.13M-11.37M3.52M3.91M4.75M
Inventory ---------------
Receivables ----------066.01K0--
Total Liabilities --3.50K41.47K18.72K---116.74K145.97K-1.30M1.57M2.38M1.30M
Current Liabilities -03.50K25.69K--38.34K47.98K116.74K141.72K-436.32K775.59K1.66M650.18K
Long Term Debt ---------------
Total Debt ---------------
Total Equity -47.48K-1.75K-41.19K1.79M846.51K1.20M407.44K-22.89K1.28M-10.34M6.18M5.03M6.31M
Shares Outstanding -----------210.59K210.61K298.96K887.88K

Cash Flows (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Dec 2013Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -46.30K-21.47K-181.61K-284.62K272.64K-794.32K-1.16M--3.50M-3.22M-3.83M-4.66M
Investing Cash Flow -----250.00K186.74K39.00K-86.71K-4.15M973.78K644.02K
Financing Cash Flow 57520.00K2.19M-19.45K382.66K2.13M-4.94M-471.12K3.24M4.86M
Capital Expenditure ------------574.92K
Free Cash Flow ---------3.50M-3.22M-3.83M-5.24M
Net Change in Cash --------1.53M-7.84M381.49K842.90K

Ratios (Annual)

Figures in %.

Metric Dec 2011Dec 2012Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ----32.5%-330.4%-91.9%91.9%91.9%38.6%
Operating Margin % -----2,293.4%-5,380.2%--5,059.0%-5,347.4%-6,526.4%-5,937.0%
Net Margin % -----2,497.7%-7,422.5%--5,420.9%-5,132.6%-6,092.6%-5,863.5%
ROE % 2,849.1%95.8%29.6%-237.9%4,426.4%-237.2%--37.8%-59.9%-87.3%-67.0%
ROCE % ---30.6%-73.6%-246.7%-171.3%--32.5%-55.3%-81.8%-61.5%

Shareholding Pattern

Insiders
16.41%
Institutions
11.13%
Public Float
13.31%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SILO

Google News Wed, 15 Jul 2026

Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPdUVsSm1qc2p3bksxMV85Z2tRUzU5ckF2cGxUa01CRjNtbnFRYWlzZ0RZdHp2Z1dtMHMyOXpURi1IMllicjQzZHUyZlB0aW5zR0QzZk5ZWXR2Rmx3bnJmLXJsRXpFbFdwTk4tZS1Qdk9rS2M2UmN3Wm02WTRsb2xEejNoM1Z1WjU4cVdlbz…

Google News Sat, 01 Aug 2026

Silo Pharma, Inc. Revenue Breakdown – NASDAQ:SILO - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE5saDBwcjc3WVVCdUJFV216Q21nZzlrNzMwV19NdGMwRGtTclJmSV9NSkY3LUN6bjNLV0JrYXg4MmIweEdJd29kUi1hNVhwRjl4RUxuUjNpbTQzai05djNYZzBaNWJoTDRRNXUzazZzNVhrQUYzaUpv?oc=5" target="_blank">Silo Ph…

Google News ue, 04 Aug 2026

SILO|Silo Pharma Inc|Price:4.210|Chg%:+0.020 - TradingKey

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE1VZzh4UlJJamw4NFVORjlDanFDa0ZabVc2UkpadkpTc21iTG1jUnFaclZDUlE1dm5fVlhFNl9TcjZPNU90WFFDamRUM0t3cW5seWRkUlFBaVVNdw?oc=5" target="_blank">SILO|Silo Pharma Inc|Price:4.210|Chg%:+0.020<…

Google News ue, 07 Apr 2026

Why Did SILO Stock Soar 85% Today? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNTXN5QmpOU041bGR6OU9oOGxGa1V5V3BRb1FHd1FZbXZWbWlaOEZ0ZHAteGFvU25qdU9QOHpFNktIT2c5T0NEZTF3YXl0ckVhWXJWYzZVelE4LVZPbGNZYXZrNzVKQ3U5c2VzNlhQRUxqLW9zamVDTy1yYVdyVHlnYnhVenVTMFF6N2hWTT…

Google News ue, 21 Jul 2026

Silo Pharma expects its PTSD nasal-spray study to finish in 60 days - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPd04zUG5pY09nQ0hhTUEwNkNlSTVrSklkUkZxTHI5bFNTWC05RmhOaVpKN0QxUm5BUzN1YTlXOFNCdFNtWldtOUVVdEZ2RkRqRVRnbFR0dXZXYnVMT01pMHRWQTRBNEV2NTJiOW1oNVZaNldCRjJrLUItTU4zN3BvYWJWMEdDblJHYWxicn…

Google News ue, 21 Jul 2026

Silo Pharma Advances QwikAgents Commercial Launch and SPC-15 Development - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNYmZQWGFGLS1wMzlidDdVVTFIYnY2SWIzRHhYSXZhdmtQM2txM0xIWldtamgtdEhsYTNpM3VxUGoxdnRkYVluTE9kejdHWGgtMlNkbW5qQzY5QUN4OHZqZHdiT0J4NlA1UkxmdzJHeHAxa2g4T3R5bkJjbWlDTGtaWFRDY0pjcEY2YXEtS1…

SILO — Frequently Asked Questions

What is the current share price of SILO?

As of 2026-08-05 17:25 PDT, SILO trades at $4.61 on NASDAQ/NYSE. Its 52-week range is $4.19 to $12.22.

What is the market capitalisation of SILO?

SILO has a market capitalisation of $4.09M on NASDAQ/NYSE.

What is the P/E ratio of SILO?

SILO trades at a trailing price-to-earnings (P/E) ratio of -0.61. Its price-to-book (P/B) ratio is 0.65.

What is the return on equity (ROE) of SILO?

SILO has a return on equity (ROE) of -67.05%. Its return on capital employed (ROCE) is -61.55%.

Is SILO a good stock to buy?

This page provides a data-driven analysis of SILO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space